Previous Article | Next Article 
Infection and Immunity, December 1999, p. 6643-6651, Vol. 67, No. 12
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Peptide Localization and Gene Structure of Cryptdin 4, a
Differentially Expressed Mouse Paneth Cell
-Defensin
Andre J.
Ouellette,1,2,*
Dalila
Darmoul,3
Dat
Tran,1,2
Kenneth M.
Huttner,4
Jun
Yuan,1 and
Michael E.
Selsted1,2
Departments of Pathology1 and
Microbiology and Molecular Genetics,2
College of Medicine, University of California, Irvine, California
92697; Neuroendocrinologie et Biologie Cellulaire Digestives,
INSERM U410, Faculté de Médicine Xavier Bichat, 75018 Paris, France3; and Section on
Neonatology, Department of Pediatrics, Massachusetts General
Hospital, Boston, Massachusetts 021144
Received 11 June 1999/Returned for modification 26 July
1999/Accepted 17 September 1999
 |
ABSTRACT |
Paneth cells in crypts of the small intestine express antimicrobial
peptides, including
-defensins, termed cryptdins in mice. Of the
known Paneth cell
-defensins, the cryptdin 4 gene is unique, because
it is inactive in the duodenum and expressed at maximal levels in the
distal small bowel (D. Darmoul and A. J. Ouellette, Am. J. Physiol. 271:G68-G74, 1996). With a cryptdin 4-specific antibody,
immunohistochemical staining of ileal Paneth cells was strong and
specific for cytoplasmic granules, demonstrating that this microbicidal
peptide is a secretory product of Paneth cells in the distal small
intestine. Consistent with the pattern of cryptdin 4 mRNA distribution
along the length of the gut, the cryptdin 4 peptide was not detected in
duodenum. Structurally, the cryptdin 4 gene resembles other Paneth cell
-defensin genes. Its two exons, transcriptional start site, intron,
splice sites, and 3' flanking sequences are characteristic of the
highly conserved mouse
-defensin genes. However, in the region
upstream of the transcriptional initiation site, the cryptdin 4 gene
contains a repeated 130-bp element that is unique to this
-defensin
gene. Every independent cryptdin 4 genomic clone examined carries the repeated element, which contains putative recognition sequences for
TF-IID-EIIA, cMyc-RS-1, and IgHC.2/CuE1.1; the repeat proximal to the
start of transcription replaces DNA at the corresponding position in
other mouse
-defensin genes. We speculate that this unique
duplicated element may have a cis-acting regulatory role in
the positional specificity of cryptdin 4 gene expression.
 |
INTRODUCTION |
Located in the crypts of
Lieberkühn, Paneth cells synthesize and release proteinaceous
granules into the lumen of the small bowel. These secretory granules
are rich in antimicrobial peptides and proteins, supporting the
hypothesis that these cells contribute to innate immunity of the
intestinal mucosa (20). Paneth cell
-defensins, also
termed cryptdins, are gene-encoded antibiotic peptides expressed by
this epithelial lineage, and mouse and human Paneth cells contain high
levels of these peptides and their corresponding mRNAs (15, 16,
18). Six cryptdin peptide variants have been purified from mouse
small intestine (7, 26), and five of those isoforms,
cryptdins 1 to 3, 5, and 6, are coded by separate genes clustered in
the proximal region of chromosome 8 (18). Transcripts of
cryptdin genes are approximately 1 kb in length and coded by two-exon
genes in which the first exon codes for the preprosegment of the
precursor and the second exon codes for the mature
-defensin peptide
(14). Human Paneth cells express two
-defensin genes,
HD-5 and HD-6 (2, 15, 16), but the mouse
-defensin gene
family is larger, coding for at least 19 different cryptdin isoforms
(18).
At the level of both the peptide and the gene, cryptdin 4 has several
features that distinguish it from the known Paneth cell
-defensins.
For example, the peptide has the highest antimicrobial activity of the
known mouse enteric
-defensins in in vitro assays (18),
and the cryptdin 4 gene has a unique pattern of expression along the
longitudinal axis of the small intestine (5). In contrast to
cryptdins 1 and 5, whose mRNAs occur at approximately equivalent levels
along the length of the mouse small bowel, cryptdin 4 mRNA levels
increase along the proximal-to-distal axis to reach maximal
concentration in the distal ileum. To test for potential structural
differences correlating with differential cryptdin 4 gene activity, DNA
sequences up-stream of mouse Paneth cell
-defensin gene
transcription initiation sites have been analyzed and compared.
Here, we demonstrate that the cryptdin 4 peptide is a Paneth cell
granule constituent, and thus is secreted into the lumen, and that
peptide distribution corresponds to the increasing cryptdin 4 mRNA
concentration along the length of the gut. Also we report on the
structure of the 129/SVJ mouse cryptdin 4 gene and show that its two
exons are identical in sequence to cryptdin 4 cDNAs from intestinal
crypts of C3H/HeJ and outbred Swiss mice. The region just upstream of
the cryptdin 4 gene transcriptional initiation site contains a 130-bp
repeated element that does not occur in other known mouse
-defensin genes.
(This work was presented in preliminary form at the Annual Meeting of
the American Gastroenterological Association, Washington, D.C., May
1997.)
 |
MATERIALS AND METHODS |
Solid-phase synthesis of cryptdin 4.
The cryptdin 4 peptide
chain was assembled on a Millipore 9050 automated continuous flow
peptide synthesizer by sodium 9-fluorenylmethoxycarbonyl methodology
(3). Amino acids were activated in situ with
N,N-diisopropylcarboxydiimide-N,N-diisopropylethylamine-1-hydroxybenzotriazole chemistry (27), and the coupling yield was monitored on line with quinoline yellow (29). The synthetic peptide was
released from the polyethylene glycol-polystyrene resin support by
treatment with trifluoroacetic acid-water-phenol-triisopropylsilane
(88:5:5:2, reagent B [27]) for 6 h at 20°C and
filtered. The peptide solution was adjusted with acetic acid (HOAc) to
a final concentration of 30%, extracted three times with equal volumes
of dichloromethane, diluted fivefold with H2O, and
lyophilized. The lyophilized peptide was dissolved in 10% HOAc and
lyophilized again prior to biochemical analysis.
Approximately 100 mg of crude synthetic peptide was linearized by
reduction for 8 h at 60°C with a solution containing 100 mM
dithiothreitol in 6 M guanidine HCl, 200 mM Tris-Cl, and 2 mM EDTA (pH
8.2) and acidified to 30% HOAc. The reduced, acidified synthetic
peptide was dialyzed stepwise against 4 liters each of the following
aqueous solutions: 30% HOAc for 24 h; 15% HOAc for 24 h;
and 1% HOAc for 24 h. The peptide was refolded in 1% sodium
acetate (pH 8.0) containing glutathione (2 mol of oxidized glutathione
and 1 mol of reduced glutathione per 20 cysteine-SH molar equivalents).
The folded peptide was purified to homogeneity by successive
reverse-phase high-pressure liquid chromatography (RP-HPLC) with Vydac
C-18 columns (diameters, 10 and 22 mm; length, 250 mm) developed with
linear gradients of water-acetonitrile containing 0.1% trifluoroacetic
acid or 0.13% heptafluorobutyric acid. Peak resolution was optimized
for each round of purification by varying the water-to-acetonitrile
gradient from 1 to 0.25% per min.
Preparation of anti-cryptdin 4 antibody.
A peptide-specific
polyclonal rabbit antibody to the synthetic, folded cryptdin 4 was
prepared. A sample (4 mg) of cryptdin 4 conjugated to ovalbumin was
used to immunize two New Zealand White rabbits (Zymed Laboratories,
Inc., San Francisco, Calif.). Serum samples were collected for 8 to 12 weeks, until the anti-cryptdin 4 titer, determined by enzyme-linked
immunosorbent assay, reached 1:10,000 for each rabbit. Immunoglobulin G
(IgG) was isolated from antiserum by DEAE Econo-Pac chromatography
(Bio-Rad, Richmond, Calif.) as described by the manufacturer. Peptide
specificity of the antibody was determined by assessing
immunoreactivity against cryptdins 1 to 6 immobilized on polyvinylidene
difluoride and nitrocellulose membranes, with the antibody
demonstrating reactivity only with cryptdin 4.
Immunohistochemical detection of cryptdin 4.
Paraffin
sections of formalin-fixed mouse small bowel were deparaffinized with
xylenes, treated for 30 min with 0.3% H2O2, and washed extensively with water and then with phosphate-buffered saline (PBS). Slides were incubated three times for 5 min each in the
microwave oven with antigen unmasking solution (Vector Laboratories,
Inc., Burlingame, Calif.) and then cooled in unmasking solution (Vector
Laboratories, Inc.) for 30 min at room temperature. After being rinsed
with PBS, the sections were blocked by incubation with normal goat
serum for 30 min and with Avidin D blocking solution for 15 min, rinsed
briefly with PBS, and then incubated with biotin blocking solution
(Vector Laboratories, Inc.) for 15 min. Slides were incubated with a
1:50 dilution of rabbit anti-cryptdin 4 IgG, a 1:10 dilution of
anti-cryptdin 4 IgG in 1× PBS preabsorbed at 4°C overnight with 80 µg of synthetic, folded cryptdin 4, or with IgG prepared from serum
of rabbits prior to immunization. After 30 min, slides were washed
three times with PBS, incubated for 30 min with a 1:200 dilution of
biotinylated goat anti-rabbit IgG, and washed as before. After 60 min
of incubation with Vectastain ABC peroxidase reagent (Vector
Laboratories, Inc.), slides were washed and flooded for 3 min with
diaminobenzidine as a peroxidase substrate, washed, counterstained with
hematoxylin, cleaned, and mounted.
Cryptdin 4 gene isolation.
Bacteriophages containing
cryptdin 4 gene sequences were identified in a 129/SVJ mouse genomic
library in
DASH II (Stratagene Cloning Systems, La Jolla, Calif.).
Phage plates (1.1 × 105 PFU/dish) were screened in
duplicate by hybridization of filter lifts with oligonucleotide cryp4
(5'-CGGCG GGGGC AGCAG TA-3'), the reverse complement of nucleotides 259 to 275 in cryptdin 4 cDNA, labeled with [
-32P]ATP by
using polynucleotide kinase (Promega Corporation, Madison, Wis.).
Conditions for hybridization and washing of filters have been described
previously (5). Subsequently, a mixed probe for putative
cryptdin gene promoter sequences was prepared by amplification of mouse
genomic DNA (30 cycles of 94°C for 40 s, 60°C for 40 s,
and 72°C for 40 s) with oligonucleotide Defcrm150 (5'-GCTGC TCCTC AGTAT TAGTC TCTT-3') paired with sense strand primer
CIA7 (5'-TAAAT (A/G)(C/T)TCA AGCAG ATGG-3'). Defcrm150 primes on the antisense strand of all known cryptdin cDNAs near the
midpoint of exon 1, and the CIA7 priming site is conserved in several
mouse Paneth cell
-defensin genes between residues
216 and
234
relative to the transcription start site (13a). This 384-bp
PCR product was used to screen Southern blots of genomic clones to
identify isolates containing sequences upstream of the transcription
start site of this gene.
DNA sequencing and analysis.
Denatured plasmid DNAs from
subcloned fragments of genomic clones were sequenced by dideoxy
nucleotide termination (23) with modified Sequenase II
(United States Biochemical Corp., Cleveland, Ohio). Computations for
similarity searches of DNA sequences in nonredundant nucleic acid and
protein sequence databases were performed at the National Center for
Biotechnology Information by using the BLAST network service (1,
12). DNA sequences were analyzed by using programs in the
University of Wisconsin Genetics Computer Group suite (6) as
well as routines in the MacVector version 4.5.3 program (Eastman Kodak
Company, Rochester, N.Y.).
Nucleotide sequence accession numbers.
The GenBank accession
number for the cryptdin 4 gene sequence (Fig. 4A) is AF178040. Those
for the 5' UTRs of cyrptdin 1, cryptdin 5, cryptdin 6, and CRS4C-2
(Fig. 4B) are AF178043, AF178042, AF178041, and AF178044, respectively.
 |
RESULTS AND DISCUSSION |
Analysis of synthetic cryptdin 4.
The cryptdin 4 peptide
(GLLCY CRKGH CKRGE RVRGT CGIRF LYCCP RR), isolated previously from
full-length, full-thickness mouse small intestine (26), is
the most potent of the known mouse Paneth cell
-defensins
(18). Because the overall recovery of cryptdin 4 from
intestinal extracts is low relative to that of cryptdins 1, 2, 5, and
6, which are expressed along the entire length of the small bowel, the
peptide was synthesized to obtain sufficient quantities of peptide for
biochemical analysis and antibody production (see Materials and
Methods). The overall peptide yield was estimated at 4.1% with a
recovery of 35 mg of RP-HPLC-purified, folded cryptdin 4 recovered from
860 mg of crude peptide. The purified synthetic cryptdin 4 peptide was
characterized by mass spectroscopy, amino acid analysis, and analytical
RP-HPLC and shown to be identical to the natural cryptdin 4 reference
peptide in all respects (data not shown). In acid-urea polyacrylamide gel electrophoresis (AU-PAGE), a system that provides high resolution of the protonated forms of defensins and small basic peptides (21,
25), the synthetic and natural cryptdin 4 peptides had identical
mobilities (Fig. 1A). As may be predicted
from their identical biochemical properties, synthetic and natural
cryptdin 4 were functionally equivalent in assays of antimicrobial
activity against Escherichia coli ML35 and
Staphylococcus aureus (Fig. 1B). Therefore, this synthetic
cryptdin 4 peptide was used for preparation of antiserum to analyze the
tissue distribution of cryptdin 4 peptide in Paneth cells along the
length of the mouse small intestine.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Characterization of synthetic cryptdin 4. Panel A,
AU-PAGE of natural (lane 1) and synthetic (lane 2) cryptdin 4. Samples
(1 µg) of peptide dissolved in 2% acetic acid were electrophoresed
for 6 h at 200 V in 12.5% polyacrylamide gels as described
previously (25) with migration toward the cathode proceeding
from top to bottom. The gel was stained with Coomassie blue as
described previously (24). Panel B, antimicrobial activities
of natural and synthetic cryptdin 4. The combined bactericidal and
bacteriostatic activities of the peptides were evaluated by a radial
diffusion assay (see Materials and Methods [18]). The
similarity of zones of bacterial growth inhibition obtained with the
corresponding natural or synthetic peptides shows that they are
functionally equivalent. Symbols: , E. coli exposed to
natural cryptdin 4; , E. coli exposed to synthetic
cryptdin 4; , S. aureus exposed to natural cryptdin 4;
, S. aureus exposed to synthetic cryptdin 4.
|
|
Localization of cryptdin 4 in mouse small intestine.
In the
small bowel, cryptdin 4 gene expression is restricted to Paneth cells,
and the highest levels of peptide occur in the distal regions of the
organ. Immunoperoxidase staining of full-thickness sections of mouse
small intestine with anti-cryptdin 4 IgG failed to identify the peptide
in the duodenum (Fig. 2A), showed
intermediate levels along the jejunum (Fig. 2B to D), and demonstrated
maximal levels in terminal ileum (Fig. 2G). In contrast to these
results, Paneth cells in duodenum are strongly immunoreactive with the anti-cryptdin 1 antibody (26). Cryptdin 4 is present in
Paneth cells at the base of every ileal crypt (Fig. 2E to G). When
sections of ileum stained with the antibody were viewed at higher
magnification, the cryptdin 4 antigen was found to be concentrated
within Paneth cell secretory granules (Fig. 3A and
B). Thus, as with the known enteric
-defensins, cryptdin 4 is a constituent of secretory granules and is
therefore released into the crypt lumen.

View larger version (122K):
[in this window]
[in a new window]
|
FIG. 2.
Immunohistochemical localization of cryptdin 4 peptide
in Paneth cells of distal mouse small intestine. Sections of adult
mouse duodenum (A), jejunum (B through D), and ileum (E through G) were
analyzed for the presence of the cryptdin 4 peptide, by using purified
IgG from a polyclonal rabbit cryptdin 4-specific antibody (see
Materials and Methods). In each panel, arrows indicate immunoperoxidase
localization in Paneth cells of the crypts. Magnification, ×40. IgG
prepared from preimmune serum is negative (H). Note that duodenal
crypts are negative, jejunal crypts are modestly positive, and ileal
crypts are strongly immunoreactive.
|
|

View larger version (133K):
[in this window]
[in a new window]
|
FIG. 3.
Cryptdin 4 in Paneth cell secretory granules. As
described for Fig. 2, sections of adult mouse ileum were incubated with
IgG prepared from polyclonal rabbit cryptdin 4-specific antiserum (A
and B), with preimmune serum (C), or with immune IgG preadsorbed with
80 µg of synthetic cryptdin 4 (D). Magnification, ×100. In panels A
and B, the arrows indicate secretory granules in Paneth cells that are
strongly immunoreactive; in panels C and D, arrows indicate
eosinophilic granules that are immunoperoxidase negative after exposure
to preimmune and preadsorbed IgG controls, respectively.
|
|
The anti-cryptdin 4 antibody used in these experiments is specific for
the cryptdin 4 isoform, and it does not cross-react
with cryptdins 1 to
3, or cryptdin 5 or 6 (data not shown). No
immunoperoxidase activity is
visible in slides treated with preimmune
IgG or IgG preabsorbed with
antigen as a negative control (Fig.
3C and D). Leukocytes in the lamina
propria of the villi also
were negative, showing that all the peptide
in the small bowel
accumulates in the epithelial compartment. A rabbit
polyclonal
antibody to synthetic cryptdin 1 displays comparable
specificity
(
26). That antibody recognizes the mouse
cryptdins 1 to 3 and
6, four cryptdin 1-like isoforms, but it does not
detect cryptdin
4 or 5, nor does it stain rat or human Paneth cells.
The immunolocalization
results (Fig.
2 and
3) correlate well with the
previous amplification
and cloning of cryptdin 4 cDNA from isolated
intestinal crypts
(
5,
18) and are consistent with the strong
positive signals
obtained by in situ hybridization of Paneth cells with

-defensin
probes (
9,
15,
17) and with the detection of
other enteric

-defensins in mouse and human cells (
22,
26).
Cryptdin 4 gene structure.
The structural features of the
cryptdin 4 gene are conserved relative to those of known mouse and
human Paneth cell
-defensin genes (Fig. 4
[14-16]). Bacteriophage clones in a 129/SVJ mouse genomic library were identified by hybridization with the cryp4 oligonucleotide (4, 5), and several isolates contained a positive, 2-kb EcoRI fragment that contained the complete
coding sequence for the cryptdin 4 precursor (see Materials and
Methods). DNA sequencing of those clones showed that the cryptdin 4 gene primary transcript is 987 nucleotides long and contains two exons (Fig. 4A). Exon 1 contains a 45-bp 5' untranslated region and sequence coding for the
preprosegment of the precursor; exon 2 codes for the mature cryptdin 4 peptide and contains approximately 100 bp of 3' untranslated sequence
(Fig. 4A). The two cryptdin 4 exons of the 129/SVJ mouse are identical
to cryptdin 4 cDNA from C3H/HeJ and outbred Swiss mice (18).
The sequences upstream of transcriptional start sites of mouse cryptdin
genes are conserved (Fig. 4B). A multiple sequence alignment produced
by the program Pileup (6) illustrates the extensive sequence
similarity between the 5' upstream regions of the cryptdin 1, 4, 5, and
6 genes and also with the defensin-related mouse CRS4C-2
(13) gene (Fig. 4B). Also, cryptdin 4-coding genomic
sequences from 129/SVJ (Fig. 4) and C3H/HeJ, BALB/cJ, and outbred Swiss
mice are identical (data not shown), as are cryptdin 4 cDNAs from
outbred Swiss and several inbred strains of mice (20a).

View larger version (76K):
[in this window]
[in a new window]
|
FIG. 4.
Nucleotide sequence and structure of the mouse
cryptdin 4 gene. (A) Overlapping fragments of cryptdin 4 genomic clones
were sequenced as described above (see Materials and Methods). The
transcribed sequence is depicted in uppercase characters; the sequence
coding for the deduced cryptdin 4 precursor is underlined; the intron,
determined by sequence alignment with cryptdin 4 cDNA (18),
is shown in uppercase italics; and untranscribed sequences in the 5'
and 3' flanking regions of the gene are shown in lowercase. The deduced
amino acid sequence of the cryptdin 4 precursor is shown in uppercase,
single-letter notation above the coding regions, with an asterisk
denoting the termination codon. The deduced polyadenylation start site
is shown as double underlined characters, beginning 21 nucleotides from
the transcription termination site. Nucleotide residue positions are
numbered with the first nucleotide of the transcription start site
assigned residue position +1. (B) Alignment of 5' upstream sequences
from mouse -defensin family genes. Sequences corresponding to
nucleotide positions 630 to +5 in four mouse cryptdin genes
(14) and in the related CRS4C-2 gene (13) were
aligned with the UWGCG program Pileup (6) by using a gap
weight of 5.00 and a gap length weight of 0.30. Dot characters (.) in
lines of sequence were introduced by the program to maximize the
alignment score. The cryptdin 4 nucleotide sequence is shown in
uppercase type with a tandemly repeated element denoted as shaded text.
Residue positions are numbered in relation to the transcriptional start
site, designated to be position +1.
|
|
Detection of new cryptdin 4 isoform.
The mouse cryptdin 1-like
-defensin subfamily has undergone gene duplication events to
generate many peptide isoforms in Mus musculus
(14, 18). However, evidence of cryptdin 4 isoforms has
not been found in outbred Swiss or in inbred strains of mice. Studies of cryptdin 4-coding sequences amplified from
genomic DNA of wild-derived strains revealed that the Mus
czech II/Ei genome codes for the following deduced cryptdin 4 peptide variant: DLTCYCRKGHCKRGGRVRGTCGIRFLYCCPRR
(replaced amino acids are indicated by italics), compared to
GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR, the primary
structure of cryptdin 4 isolated from M. musculus
domesticus. To our knowledge, the M. czech II/Ei
cryptdin 4 variant, with D1G, T3L, and G15E amino acid replacements,
represents the first evidence of evolutionary diversity of this
particular
-defensin gene in mice.
Tandemly repeated element specific to the cryptdin 4 gene.
Dot
matrix alignments of sequences corresponding to 600 bp 5' of the
transcriptional start sites of the cryptdin 1 gene and the cryptdin 5 and 6 genes produce continuous diagonal lines, indicative of their 95%
nucleotide sequence identities (Fig. 5Aa and
Ab). However, a similar comparison of the
cryptdin 1 and cryptdin 5 genes with the cryptdin 4 gene sequence
showed that the 5' flanking DNA of the cryptdin 4 gene contains a
distinctive, tandemly repeated element (Fig. 5Ac and 5d). The alignment
of the cryptdin 1 and cryptdin 4 upstream regions becomes discontinuous
near nucleotide position
300 (Fig. 5Ac), indicative of a direct
repeat in the region upstream of the cryptdin 4 gene transcriptional
start site. We infer that the second repeat and the 70 bp adjacent to
its 3' end, i.e., nucleotides
270 to
70, have replaced DNA present in other mouse Paneth cell
-defensin genes, because the
corresponding regions (nucleotides
270 to
70) of the cryptdin 1, 5, and 6 genes lack similarity with the cryptdin 4 repeated element (data not shown). The tandem repeats, located from nucleotides
495 to
365
and
270 to
140 (Fig. 5B) are nearly identical in sequence, except
that the element distal to the initiation site has a 3-bp gap (data not
shown). The role of this duplicated element and the doubling of certain
putative transcription factor binding sites in the regulation of
cryptdin 4 gene activity remains to be determined, but to our
knowledge, no known
-defensin genes contain such a structural
feature.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 5.
A repeated sequence element upstream of the
cryptdin 4 gene transcriptional start site. (A) DNA sequences in the
region from positions +1 to 700 upstream of the cryptdin genes shown
were compared by the Pustell dot matrix alignment routine in the
MacVector suite (see Materials and Methods). In contrast to comparisons
of cryptdins 1 and 6 (a) as well as of cryptdins 1 and 5 (b), which
were colinear and nearly identical, alignment comparisons involving the
cryptdin 4 gene revealed a discontinuity in the sequence alignment that
is indicative of a tandem repeat (c and d). (B) Potential transcription
factor recognition sites (10, 11, 28) in the region upstream
of the cryptdin 4 transcriptional start site are indicated in uppercase
type and identified above lines of nucleotide sequence. The duplicated
element described for panel A, from nucleotides 494 to 367 and
269 to 140, is indicated by shaded text. (C) The only region of
similarity between the 1.2 kb of nucleotide sequence 5' of the mouse
cryptdin 4 and human HD-5 Paneth cell -defensin gene transcription
start sites is shown. Nucleotide sequences from the 5' untranscribed
regions of cryptdin 4 and HD-5 genes were aligned using the program
Bestfit. Pluses between lines of DNA sequence denote identical
nucleotide positions. Conserved potential DNA recognition sequences for
AP-1 (italics), Oct 1.4 (double underlining), and GCRE/GCN4-HIS (single
underlining) transcription factors are indicated.
|
|
Sequences upstream of the 129/SVJ mouse cryptdin 4 gene were compared
with those of mouse and human Paneth cell

-defensin
genes to
identify putative transcriptional regulatory sites near
the
transcription initiation site. Because the 2.0-kb
EcoRI
cryptdin
4 gene DNA fragment contained only 230 bp of 5' upstream
sequence,
clones with additional DNA upstream of the transcriptional
start
site were isolated with a hybridization probe consisting of
nucleotides

225 to +150 of the cryptdin 4 gene. Subcloned restriction
fragments
were sequenced, revealing the presence of several consensus
transcription
factor binding sites within 1.15 kb of the
transcriptional start
site, including TFIID-EIIA, Oct 1.4, AP-1,
GATA-1, NF-E1, PEA3,
GRE, and C/EBP sites of potential regulatory
importance (Fig.
5B). Also, between the nucleotides at positions

1000
and

930
relative to the transcriptional start site, the gene contains
a continuous tract of alternating purines and pyrimidines, a motif
known to modulate transcription by introducing Z-DNA structures
(Fig.
5B). Comparisons of the regions consisting of 1.15 kb immediately
upstream of the mouse cryptdin 4 and human HD-5

-defensin genes
by
Bestfit (
6) and by Pustell dot matrix alignment analyses
(see Materials and Methods) showed that the genes lack overall
similarity, but between nucleotides

340 and

310, they share
putative AP-1, Oct-1.4, and GCRE DNA binding sites (Fig.
5C).
The
involvement of these apparent recognition sequences in regulating
transcription of the cryptdin 4 gene or of any Paneth cell

-defensin
gene is not known, because cell lines that express constructs
of
reporter transgenes under the control of putative cryptdin
gene
promoters are not available. Interestingly, a mouse line
transgenic for
an HD-5 minigene construct expresses the human
gene appropriately in
small intestinal crypts (
14a), providing
preliminary
evidence that human and mouse Paneth cell

-defensin
gene promoters
may contain conserved
cis-acting elements. At present,
however, the lack of systems for functional analysis of Paneth
cell-specific gene promoters precludes definition of the role
of those
putative recognition
sequences.
The repeated upstream element was found in every cryptdin 4 genomic
clone isolated. To confirm that the cryptdin 4 gene containing
the
tandemly repeated element was representative of the functional
gene,
eight cryptdin 4 genomic clones, judged to be independent
isolates on
the basis of their distinctive restriction patterns,
were tested for
the presence of the repeated element. The region
comprising the
repeated elements was amplified with oligonucleotides
Cr4ut630,
corresponding to residue positions

585 to

561 on the
sense strand
(5'-GAATC TCAAT CATGT GGAAT GACG-3') paired with
Cr4ut110,
corresponding to nucleotides

125 to

110 on the antisense
strand
(5'-ATGTC CTGAA GCCTA CTATC ATGAT-3'), by using 35 cycles
at
94°C for 40 s, 55°C for 40 s, and 72°C for 40 s.
One genomic
clone, phage D (

D), contained only 223 bp upstream of
the transcriptional
start site and provided a negative control, since
it lacks the
upstream priming site. DNA corresponding to the region
containing
the repeat was amplified, and samples of each reaction were
electrophoresed
to distinguish between PCR fragments indicative of two
(473 bp)
or one (345 bp) copy of the repeated element (data not shown).
The duplicated element was detected in every clone, except for
the

D
negative control, and restriction analyses confirmed that
the 473-bp
PCR fragment contained two repeats and therefore that
all cryptdin 4 genomic isolates contained the tandemly repeated
DNA (data not
shown).
The cryptdin 4 gene shares the general features of the two-exon Paneth
cell

-defensin genes, and comparisons of mouse cryptdin
gene
sequences upstream of their highly conserved transcriptional
start site
(
13,
14) revealed extensive similarities but also
the
presence of a repeated element unique to the cryptdin 4 gene
(Fig.
5
and data not shown). The molecular mechanism(s) regulating
the
distinctive, proximal-to-distal pattern of cryptdin 4 gene
expression
(
5) remains unexplained by these nucleotide sequence
comparisons. In addition, seven pedigrees of mice transgenic for
1.15 kb of cryptdin 4 gene 5' upstream DNA with a luciferase promoter
failed
to express the transgene in the small intestine (
4a).
Perhaps a silencer element(s) outside of the region analyzed is
involved in inactivating the gene in the proximal intestine. Since
the
cryptdin 4 gene intron has pyrimidine-rich islands and an
oligo(T)
18 tract not found in introns of other cryptdin
genes
(data not shown), we cannot exclude the possibility that the
intron
may have regulatory importance. Consensus transcription factor
recognition sequences (
10,
11,
28) that are associated with
tissue-specific gene expression in other systems (
8) were
found
both within the intron and upstream of the cryptdin 4 gene
transcriptional
start
site.
The recovery of cryptdin 4 from extracts of full-length, full-thickness
mouse small bowel is low relative to that for cryptdins
1, 2, 5, and 6 (
19), and therefore it was necessary to exclude
the
possibility that the peptide might be released along a constitutive
basolateral route rather than trafficking along the exocytic pathway
for secretion. Experiments showing that the peptide is an abundant
constituent of ileal Paneth cell secretory granules (Fig.
2 and
3) both
demonstrated that cryptdin 4 is secreted apically and
confirmed the
increasing proximal-to-distal distribution of the
peptide as predicted
by genetic evidence (
5). Two additional
lines of evidence
support the conclusion that cryptdin 4 is secreted
into the crypt
lumen. First, cryptdin 4 and a modified (des-Gly)-cryptdin
4 variant
have been isolated from rinses of the mouse small intestinal
lumen
(
19). Second, by using the cryptdin 4 antibody (Fig.
2 and
3) for enzyme-linked immunosorbent assay and Western blot
analysis,
cryptdin 4 has been detected in secretions collected
from isolated
crypts stimulated to degranulate with carbamyl choline
(
1a).
Collectively, these findings implicate this position-specific,
enteric

-defensin in mucosal innate
immunity.
 |
ACKNOWLEDGMENTS |
This work was supported by NIH grants DK44632 and DK33506
(A.J.O.) and by NIH grant AI 22931 and Biosource Technologies, Inc. (M.E.S.).
We thank Robert S. Akeson, Dana Frederick, Robin Huffman, Joseph S. Piraino, and Hong Yang for excellent technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, University of California College of Medicine, Irvine, CA
92697-4800. Phone: (949) 824-4647. Fax: (949) 824-1098. E-mail:
aouellet{at}uci.edu.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1991.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410.
|
| 1a.
| Ayabe, T., D. P. Satchell, M. E. Selsted,
C. L. Wilson, and A. J. Ouellette. Unpublished results.
|
| 2.
|
Bevins, C. L.
1994.
Antimicrobial peptides as agents of mucosal immunity, p. 250-269.
In
J. Marsh, and J. A. Goode (ed.), Antimicrobial peptides. John Wiley & Sons, Chichester, England.
|
| 3.
|
Choi, H., and J. V. Aldrich.
1993.
Comparison of methods for the Fmoc solid-phase synthesis and cleavage of a peptide containing both tryptophan and arginine.
Int. J. Pept. Protein Res.
42:42-58.
|
| 4.
|
Darmoul, D.,
D. Brown,
M. E. Selsted, and A. J. Ouellette.
1997.
Cryptdin gene expression in developing mouse small intestine.
Am. J. Physiol.
272:G197-G206[Abstract/Free Full Text].
|
| 4a.
| Darmoul, D., D. M. Frederick, and A. J. Ouellette. Unpublished results.
|
| 5.
|
Darmoul, D., and A. J. Ouellette.
1996.
Positional specificity of defensin gene expression reveals Paneth cell heterogeneity in mouse small intestine.
Am. J. Physiol.
271:G68-G74[Abstract/Free Full Text].
|
| 6.
|
Devereux, J.,
P. Haeberli, and O. Smithies.
1985.
A comprehensive set of sequence analysis programs for the VAX.
Nucleic Acids Res.
12:387-395.
|
| 7.
|
Eisenhauer, P. B.,
S. S. Harwig, and R. I. Lehrer.
1992.
Cryptdins: antimicrobial defensins of the murine small intestine.
Infect. Immun.
60:3556-3565[Abstract/Free Full Text].
|
| 8.
|
Faisst, S., and S. Meyer.
1992.
Compilation of vertebrate-encoded transcription factors.
Nucleic Acids Res.
20:3-26[Free Full Text].
|
| 9.
|
Ganz, T.,
L. Liu,
E. V. Valore, and A. Oren.
1993.
Posttranslational processing and targeting of transgenic human defensin in murine granulocyte, macrophage, fibroblast, and pituitary adenoma cell lines.
Blood
82:641-650[Abstract/Free Full Text].
|
| 10.
|
Ghosh, D.
1992.
TFD: the transcription factors database.
Nucleic Acids Res.
20(Suppl.):2091-2093.
|
| 11.
|
Ghosh, D.
1993.
Status of the transcription factors database (TFD).
Nucleic Acids Res.
21:3117-3118[Abstract/Free Full Text].
|
| 12.
|
Gish, W., and D. J. States.
1993.
Identification of protein coding regions by database similarity search.
Nat. Genet.
3:266-272[Medline].
|
| 13.
|
Huttner, K. M., and A. J. Ouellette.
1994.
A family of defensin-like genes codes for diverse cysteine-rich peptides in mouse Paneth cells.
Genomics
24:99-109[Medline].
|
| 13a.
| Huttner, K. M., and A. J. Ouellette.
Unpublished results.
|
| 14.
|
Huttner, K. M.,
M. E. Selsted, and A. J. Ouellette.
1994.
Structure and diversity of the murine cryptdin gene family.
Genomics
19:448-453[Medline].
|
| 14a.
| Huttner, K. M., N. Salzman, and C. L. Bevins. Unpublished results.
|
| 15.
|
Jones, D. E., and C. L. Bevins.
1992.
Paneth cells of the human small intestine express an antimicrobial peptide gene.
J. Biol. Chem.
267:23216-23225[Abstract/Free Full Text].
|
| 16.
|
Jones, D. E., and C. L. Bevins.
1993.
Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel.
FEBS Lett.
315:187-192[Medline].
|
| 17.
|
Ouellette, A. J.,
R. M. Greco,
M. James,
D. Frederick,
J. Naftilan, and J. T. Fallon.
1989.
Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium.
J. Cell Biol.
108:1687-1695[Abstract/Free Full Text].
|
| 18.
|
Ouellette, A. J.,
M. M. Hsieh,
M. T. Nosek,
D. F. Cano-Gauci,
K. M. Huttner,
R. N. Buick, and M. E. Selsted.
1994.
Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.
Infect. Immun.
62:5040-5047[Abstract/Free Full Text].
|
| 19.
|
Ouellette, A. J.,
M. M. Hsieh, and M. E. Selsted.
1996.
Structure and function of cryptdins isolated from mouse small intestinal lumen.
Gastroenterology
110(Suppl.):A985.
|
| 20.
|
Ouellette, A. J., and M. E. Selsted.
1996.
Paneth cell defensins: endogenous peptide components of intestinal host defense.
FASEB J.
10:1280-1289[Abstract].
|
| 20a.
| Ouellette, A. J. Unpublished observations.
|
| 21.
|
Panyim, S., and R. Chalkley.
1969.
High resolution acrylamide gel electrophoresis of histones.
Arch. Biochem. Biophys.
130:337-346[Medline].
|
| 22.
|
Porter, E. M.,
L. Liu,
A. Oren,
P. A. Anton, and T. Ganz.
1997.
Localization of human intestinal defensin 5 in Paneth cell granules.
Infect. Immun.
65:2389-2395[Abstract].
|
| 23.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 24.
|
Selsted, M. E.
1993.
Investigational approaches for studying the structures and biological functions of myeloid antimicrobial peptides.
Genet. Eng.
15:131-147.
|
| 25.
|
Selsted, M. E., and H. W. Becker, III.
1986.
Eosin Y: a reversible stain for detecting electrophoretically resolved protein.
Anal. Biochem.
155:270-274[Medline].
|
| 26.
|
Selsted, M. E.,
S. I. Miller,
A. H. Henschen, and A. J. Ouellette.
1992.
Enteric defensins: antibiotic peptide components of intestinal host defense.
J. Cell Biol.
118:929-936[Abstract/Free Full Text].
|
| 27.
|
Van Abel, R. J.,
Y. Q. Tang,
V. S. V. Rao,
C. H. Dobbs,
D. Tran,
G. Barany, and M. E. Selsted.
1995.
Synthesis and characterization of indolicidin, a tryptophan-rich antimicrobial peptide from bovine neutrophils.
Int. J. Pept. Protein Res.
45:401-409[Medline].
|
| 28.
|
Wingender, E.,
P. Dietze,
H. Karas, and R. Kneuppel.
1996.
TRANSFAC: a database on transcription factors and their DNA binding sites.
Nucleic Acids Res.
24:238-241[Abstract/Free Full Text].
|
| 29.
|
Young, S. C.,
P. D. White,
J. W. Davies,
E. E. I. A. Owen,
S. A. Salisbury, and E. J. Tremeer.
1990.
Counterion distribution monitoring a novel method for acylation monitoring in solid-phase peptide synthesis.
Biochem. Soc. Trans.
18:1311-1312[Medline].
|
Infection and Immunity, December 1999, p. 6643-6651, Vol. 67, No. 12
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vasudevan, S., Yuan, J., Osapay, G., Tran, P., Tai, K., Liang, W., Kumar, V., Selsted, M. E., Cocco, M. J.
(2008). Synthesis, Structure, and Activities of an Oral Mucosal {alpha}-Defensin from Rhesus Macaque. J. Biol. Chem.
283: 35869-35877
[Abstract]
[Full Text]
-
Wakabayashi, H., Takakura, N., Yamauchi, K., Tamura, Y.
(2006). Modulation of Immunity-Related Gene Expression in Small Intestines of Mice by Oral Administration of Lactoferrin. CVI
13: 239-245
[Abstract]
[Full Text]
-
Dorschner, R. A., Lopez-Garcia, B., Peschel, A., Kraus, D., Morikawa, K., Nizet, V., Gallo, R. L.
(2006). The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J.
20: 35-42
[Abstract]
[Full Text]
-
Cario, E
(2005). BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2. Gut
54: 1182-1193
[Full Text]
-
Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G., Flavell, R. A.
(2005). Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract. Science
307: 731-734
[Abstract]
[Full Text]
-
Clarke, L. L., Gawenis, L. R., Bradford, E. M., Judd, L. M., Boyle, K. T., Simpson, J. E., Shull, G. E., Tanabe, H., Ouellette, A. J., Franklin, C. L., Walker, N. M.
(2004). Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice. Am. J. Physiol. Gastrointest. Liver Physiol.
286: G1050-G1058
[Abstract]
[Full Text]
-
Lynn, D. J., Lloyd, A. T., Fares, M. A., O'Farrelly, C.
(2004). Evidence of Positively Selected Sites in Mammalian {alpha}-Defensins. Mol Biol Evol
21: 819-827
[Abstract]
[Full Text]
-
Tanabe, H., Yuan, J., Zaragoza, M. M., Dandekar, S., Henschen-Edman, A., Selsted, M. E., Ouellette, A. J.
(2004). Paneth Cell {alpha}-Defensins from Rhesus Macaque Small Intestine. Infect. Immun.
72: 1470-1478
[Abstract]
[Full Text]
-
Cunliffe, R. N., Mahida, Y. R.
(2004). Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol.
75: 49-58
[Abstract]
[Full Text]
-
Satchell, D. P., Sheynis, T., Shirafuji, Y., Kolusheva, S., Ouellette, A. J., Jelinek, R.
(2003). Interactions of Mouse Paneth Cell alpha -Defensins and alpha -Defensin Precursors with Membranes. PROSEGMENT INHIBITION OF PEPTIDE ASSOCIATION WITH BIOMIMETIC MEMBRANES. J. Biol. Chem.
278: 13838-13846
[Abstract]
[Full Text]
-
Shirafuji, Y., Tanabe, H., Satchell, D. P., Henschen-Edman, A., Wilson, C. L., Ouellette, A. J.
(2003). Structural Determinants of Procryptdin Recognition and Cleavage by Matrix Metalloproteinase-7. J. Biol. Chem.
278: 7910-7919
[Abstract]
[Full Text]
-
Ayabe, T., Satchell, D. P., Pesendorfer, P., Tanabe, H., Wilson, C. L., Hagen, S. J., Ouellette, A. J.
(2002). Activation of Paneth Cell alpha -Defensins in Mouse Small Intestine. J. Biol. Chem.
277: 5219-5228
[Abstract]
[Full Text]
-
Ouellette, A. J., Satchell, D. P., Hsieh, M. M., Hagen, S. J., Selsted, M. E.
(2000). Characterization of Luminal Paneth Cell alpha -Defensins in Mouse Small Intestine. ATTENUATED ANTIMICROBIAL ACTIVITIES OF PEPTIDES WITH TRUNCATED AMINO TERMINI. J. Biol. Chem.
275: 33969-33973
[Abstract]
[Full Text]
-
Yue, G., Merlin, D., Selsted, M. E., Lencer, W. I., Madara, J. L., Eaton, D. C.
(2002). Cryptdin 3 forms anion selective channels in cytoplasmic membranes of human embryonic kidney cells. Am. J. Physiol. Gastrointest. Liver Physiol.
282: G757-G765
[Abstract]
[Full Text]